The FDA says it is okay to start prescribing even though it’s effectiveness has not been tested beyond nine weeks.
Intuniv (guanfacine) is now available for children, age 4 to 17, diagnosed with ADHD. Merely using stimulants isn't enough. Now they can prescribe an additional drug that lowers blood pressure.
Side effects include: 30-40% sleepiness; 25% headache; 17% reported upper respiratory tract infection; 10% sedation. Other possible side effects that may be an issue: head injury, suicidal ideation.
In one study, 5 participants out of 262 (1.9%) who took Intuniv experienced syncope, or “temporary loss of consciousness.” In layman’s terms, they fainted or blacked out.
See this Amp at http://amplify.com/u/bs7a2
No comments:
Post a Comment